Abbreviation Description
10vPCV 10-valent pneumococcal conjugate vaccine
13vPCV 13-valent pneumococcal conjugate vaccine
23vPPV 23-valent pneumococcal polysaccharide vaccine
2vHPV bivalent HPV vaccine
4vHPV quadrivalent HPV vaccine
4vMenCV quadrivalent meningococcal conjugate vaccine
4vMenPV quadrivalent meningococcal polysaccharide vaccine
7vPCV 7-valent pneumococcal conjugate vaccine
ABLV Australian bat lyssavirus
ACT Australian Capital Territory
ADRS Adverse Drug Reactions System
AEFI adverse event following immunisation
AIDS acquired immunodeficiency syndrome
anti-HBc antibody to hepatitis B core antigen
anti-HBe antibody to hepatitis B e antigen
anti-HBs antibody to hepatitis B surface antigen
AOM acute otitis media
ASCIA Australasian Society of Clinical Immunology and Allergy
ATAGI Australian Technical Advisory Group on Immunisation
BCG bacille Calmette-Guérin
CCID50 cell culture infectious dose 50%
CDNA Communicable Diseases Network Australia
CI confidence interval
CIN cervical intraepithelial neoplasia
CRS congenital rubella syndrome
CSF cerebrospinal fluid
DNA deoxyribonucleic acid
DT diphtheria-tetanus vaccine
dT diphtheria-tetanus vaccine for use in adults
DTPa diphtheria-tetanus-acellular pertussis vaccine
dTpa diphtheria-tetanus-acellular pertussis vaccine, reduced antigen content formulation
DTPw diphtheria-tetanus-whole-cell pertussis vaccine
EIA enzyme immunoassay
ELISA enzyme-linked immunosorbent assay
FHA filamentous haemagglutinin
FIM fimbriae (pertussis)
GBS Guillain-Barré syndrome
GP general practitioner
GVHD graft-versus-host disease
HAV hepatitis A virus
HBcAg hepatitis B core antigen
HBeAg hepatitis B e antigen
HBIG hepatitis B immunoglobulin
HBsAg hepatitis B surface antigen
HBV hepatitis B virus
HCW healthcare worker
HDCV human diploid cell vaccine (rabies)
HepA hepatitis A vaccine
HepB hepatitis B vaccine
HHE hypotonic-hyporesponsive episode
Hib Haemophilus influenzae type b
Hib-MenCCV Haemophilus influenzae type b-meningococcal C conjugate vaccine
HIV human immunodeficiency virus
HPV human papillomavirus
HRIG human rabies immunoglobulin
HSCT haematopoietic stem cell transplant
HZ herpes zoster
ID intradermal
IgA/G/M immunoglobulin A/G/M
IM intramuscular
IPD invasive pneumococcal disease
IPV inactivated poliomyelitis vaccine
IS intussusception
ITP idiopathic thrombocytopenia purpura
IU international units
IV intravenous
IVIG intravenous immunoglobulin
JE Japanese encephalitis
LT-ETECheat labile toxin producing enterotoxigenic Escherichia coli
MenCCV meningococcal serogroup C conjugate vaccine
MMR measles-mumps-rubella
MMRV measles-mumps-rubella-varicella
NCIRS National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases
NHIG normal human immunoglobulin
NHMRC National Health and Medical Research Council
NIP National Immunisation Program. The National Immunisation Program (NIP) was set up by the Commonwealth and state and territory governments in 1997. It aims to increase national immunisation coverage to reduce the number of cases of diseases that are preventable by vaccination in Australia. For more information visit the National Immunisation Program ( and the National Immunisation Program Schedule ( on
NSW New South Wales
NT Northern Territory
NTHi non-typeable Haemophilus influenzae
OPV oral poliomyelitis vaccine
PCECV purified chick embryo cell vaccine (rabies)
PCR polymerase chain reaction
PEP post-exposure prophylaxis
pH1N1 pandemic influenza A(H1N1)pdm09
PHN post-herpetic neuralgia
PI product information
PreP pre-exposure prophylaxis
PRN pertactin
PRP polyribosylribitol phosphate
PRP-OMP PRP conjugated to the outer membrane protein of Neisseria meningitidis
PRP-T PRP conjugated to tetanus toxoid
PT pertussis toxoid
Qld Queensland
RCT randomised controlled trial
RIG rabies immunoglobulin
RNA ribonucleic acid
SA South Australia
SC subcutaneous
SCID severe combined immunodeficiency
SIDS sudden infant death syndrome
SOT solid organ transplant
SSPE subacute sclerosing panencephalitis
Tas Tasmania
TB tuberculosis
TCID50 tissue culture infectious dose 50%
TGA Therapeutic Goods Administration
TIG tetanus immunoglobulin
TST tuberculin skin test
Vic Victoria
VLP virus-like particle
VNAb (rabies) virus neutralising antibody
VPD vaccine-preventable disease
VV varicella vaccine
VZV varicella-zoster virus
WA Western Australia
WHO World Health Organization
ZIG zoster immunoglobulin

Page history

Last updated: 
8 May 2017
Last reviewed: 
18 January 2018